Real-time enrollment status for this insomia disorder clinical trial
Current Status
Recruiting
Checked: November 6, 2026 at 10:31 AM UTC
| NCT Number | NCT07843329 |
| Recruiting Status | Recruiting |
| Condition | Insomia Disorder |
| Phase | PHASE3 |
| Target Enrollment | 344 participants |
| Active Locations | 9 sites in the US |
| Sponsor | Idorsia Pharmaceuticals Ltd. |
| Last Updated on CT.gov | November 5, 2026 (Yesterday) |
As of November 6, 2026: Clinical trial NCT07843329 is currently recruiting participants. This phase3 study for insomia disorder is actively seeking new participants at 9 locations across the United States. The study is sponsored by Idorsia Pharmaceuticals Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07843329 is actively recruiting participants as of November 6, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 9 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07843329 was last updated Yesterday (November 5, 2026). HelloStudys verifies this status automatically.